广州市代孕协会
您的位置:主页 > 试管婴儿 >
当前位置
米非司酮联合利凡诺羊膜腔注射在中期妊娠引产
文章来源:http://www.kxabc.com  发布日期:2019-05-23

  文档介绍:

  米非司***联合利凡诺羊膜腔注射在中期妊娠引产的临床观察

米非司酮联合利凡诺羊膜腔注射在中期妊娠引产

  广东省电白县人民医院妇产科 525400

  【摘要】目的探索中期妊娠引产的安全可靠,易于患者接受的方法。方法将我院2006年1月至2009年12月在我院住院要求终止妊娠的孕妇90例,分口服米非司***加利凡诺羊膜腔注射引产组和利凡诺羊膜腔注射引产组,总产程、引产成功率、胎盘胎膜残留、滞留及清宫进行比较。结果单纯利凡诺羊膜腔注射引产术临床应用很广泛,其成功率在98%以上。但其缺点是易造成胎盘、胎膜残留,常需要常规清宫。米非司***作为利凡诺引产前用药可以软化宫颈,使宫颈扩张,是减少软产道损伤的理想药物。结论利凡诺羊膜腔注射中期妊娠引产术之前口服米非司***,两者配伍具有互补协同作用,可减少产后出血芜湖意外怀孕援助站 量,降低胎盘胎膜残留率,缩短总产程,值得临床应用。

  【关键词】米非司***;利凡诺;中期妊娠;引产

  Clinical observation of the effect of mifepristone and acrinol with amniotic cavity injection in induction of 辅助受孕和试管labor in midpregnancy

米非司酮联合利凡诺羊膜腔注射在中期妊娠引产

  Abstract Objective:To explore the safety and easily to receptived method ininduction of labor in midpregnancy.Method: We dividatur the 90pregnant woman who request to terminate pregnancy from 2006.1 to 2009.12 in two groups.One isamniotic cavity injection of acrinol,and the other is amniotic cavity injection of binatiate withmifepristone.pare the total stage of labor,artificial labor achievement ratio,birth membranes residual,stagnation and schedul hystera. 男子助孕吃什么 Result:Single amniotic cavity injection of acrinol is generally used in clinic and the achievement ratio reach above 98%,but it had some demerits,such as placenta and birth membranes 有無人食dhea幫助懷孕呀 residual,so it need to routine schedul hystera.Mifepristone was gave before rivanolinduction of labour could emolliate cervix uteri

  ,dilat. cervix uteri,decrease impairment of soft birth canal.Conclusion:Mifepristone gave before rivanolin

  内容来自淘豆网www.taodocs.com转载请标明出处.